SI2429510T1 - Emulzija olja v vodi mometazona in propilen glikola - Google Patents

Emulzija olja v vodi mometazona in propilen glikola

Info

Publication number
SI2429510T1
SI2429510T1 SI201031007T SI201031007T SI2429510T1 SI 2429510 T1 SI2429510 T1 SI 2429510T1 SI 201031007 T SI201031007 T SI 201031007T SI 201031007 T SI201031007 T SI 201031007T SI 2429510 T1 SI2429510 T1 SI 2429510T1
Authority
SI
Slovenia
Prior art keywords
mometasone
oil
propylene glycol
water emulsion
emulsion
Prior art date
Application number
SI201031007T
Other languages
English (en)
Inventor
Henri Hansson
Anna Karin Moren
Original Assignee
Galenica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica Ab filed Critical Galenica Ab
Publication of SI2429510T1 publication Critical patent/SI2429510T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SI201031007T 2009-05-12 2010-05-12 Emulzija olja v vodi mometazona in propilen glikola SI2429510T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200900601 2009-05-12
EP10721697.0A EP2429510B1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol
PCT/EP2010/002921 WO2010130428A1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol

Publications (1)

Publication Number Publication Date
SI2429510T1 true SI2429510T1 (sl) 2015-10-30

Family

ID=42352732

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201031007T SI2429510T1 (sl) 2009-05-12 2010-05-12 Emulzija olja v vodi mometazona in propilen glikola

Country Status (20)

Country Link
US (2) US8728497B2 (sl)
EP (2) EP2962688B1 (sl)
JP (2) JP5833541B2 (sl)
CN (1) CN102458382B (sl)
AU (1) AU2010246613B2 (sl)
BR (1) BRPI1010907B8 (sl)
CA (1) CA2761739C (sl)
CY (1) CY1116667T1 (sl)
DK (1) DK2429510T3 (sl)
ES (2) ES2547556T3 (sl)
HR (1) HRP20150959T1 (sl)
HU (1) HUE027718T2 (sl)
MX (1) MX345888B (sl)
NZ (1) NZ596429A (sl)
PL (2) PL2429510T3 (sl)
PT (1) PT2429510E (sl)
RU (1) RU2526911C2 (sl)
SI (1) SI2429510T1 (sl)
SM (1) SMT201500297B (sl)
WO (1) WO2010130428A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5833541B2 (ja) 2009-05-12 2015-12-16 ガレニカ エービーＧａｌｅｎｉｃａ Ａｂ モメタゾンとプロピレングリコールとの水中油型エマルジョン
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
WO2019082873A1 (ja) * 2017-10-23 2019-05-02 マルホ株式会社 被膜形成外用剤
WO2019182969A1 (en) * 2018-03-19 2019-09-26 Essential Lipid Technologies, LLC Topical phospholipid formulations and methods for preparing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282216A (en) * 1977-04-20 1981-08-04 Johnson & Johnson Topical anti-inflammatory drug therapy
US4808610A (en) 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
AU6974191A (en) * 1989-12-20 1991-07-18 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
EP1878664B1 (en) 2002-08-27 2011-03-30 Schering Corporation Process for producing metered dose inhaler formulations
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US20070179152A1 (en) 2003-05-23 2007-08-02 Lee Margaret S Combination therapy for the treatment of neoplasms
WO2004105686A2 (en) * 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
DE102006034883A1 (de) 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
JP5833541B2 (ja) 2009-05-12 2015-12-16 ガレニカ エービーＧａｌｅｎｉｃａ Ａｂ モメタゾンとプロピレングリコールとの水中油型エマルジョン
PT2429490T (pt) 2009-05-12 2017-02-08 Galenica Ab Emulsão de óleo em água de mometasona

Also Published As

Publication number Publication date
ES2813400T3 (es) 2021-03-23
CN102458382A (zh) 2012-05-16
RU2011150246A (ru) 2013-06-20
CA2761739A1 (en) 2010-11-18
NZ596429A (en) 2013-08-30
JP5833541B2 (ja) 2015-12-16
PL2429510T3 (pl) 2015-12-31
US20140242171A1 (en) 2014-08-28
AU2010246613B2 (en) 2014-07-17
CY1116667T1 (el) 2017-03-15
MX2011011959A (es) 2012-05-08
JP2012526738A (ja) 2012-11-01
DK2429510T3 (en) 2015-09-28
CA2761739C (en) 2017-03-07
BRPI1010907B8 (pt) 2021-05-25
WO2010130428A1 (en) 2010-11-18
US8728497B2 (en) 2014-05-20
PT2429510E (pt) 2015-10-12
MX345888B (es) 2017-02-22
JP2015227354A (ja) 2015-12-17
EP2962688A1 (en) 2016-01-06
BRPI1010907B1 (pt) 2020-10-20
HRP20150959T1 (hr) 2015-11-06
HUE027718T2 (en) 2016-10-28
PL2962688T3 (pl) 2020-11-02
ES2547556T3 (es) 2015-10-07
EP2962688B1 (en) 2020-06-24
RU2526911C2 (ru) 2014-08-27
US11395827B2 (en) 2022-07-26
CN102458382B (zh) 2015-03-18
EP2429510B1 (en) 2015-06-24
EP2429510A1 (en) 2012-03-21
SMT201500297B (it) 2016-01-08
AU2010246613A1 (en) 2011-12-08
BRPI1010907A2 (pt) 2016-03-15
US20120171252A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
HK1246147A1 (zh) 聚乙二醇基腎上腺髓質素前藥及其用途
HK1196550A1 (en) Water-in-oil emulsion sunscreen cosmetic
HK1170947A1 (en) W/o emulsion cosmetic w/o
EP2586811A4 (en) HIERÉRO-POLYETHYLENE GLYCOL BRANCHED AND INTERMEDIATE
EP2392312A4 (en) ANTISOLAR COSMETICS IN EMULSION OF WATER-IN-OIL TYPE
HK1178080A1 (en) Water-in-oil emulsion sunscreen cosmetic composition
EP2559423A4 (en) EMULSION COMPOSITION OIL IN WATER
ZA201108661B (en) Oil-in-water emulsion
EP2610310A4 (en) EMULSION WATER / OIL, MOUSSE AND FUNCTIONAL FOAM
PT3103784T (pt) Preparação de uma emulsão óleo-em-água que compreende esqualeno
EP2578204A4 (en) OIL-LIKE EMULSION COMPOSITION IN WATER
EP2415458A4 (en) OIL-IN-WATER EMULSION COMPOUND
HK1184066A1 (zh) 油包水型乳化化妝品
HK1171387A1 (en) Oil-in-water emulsion sunscreen cosmetic composition
EP2560626A4 (en) EMULSIONAL COMPOSITIONS FOR LOCAL ANESTHESIA AND METHOD FOR THE PRODUCTION AND USE THEREOF
ZA201108660B (en) Oil-in-water emulsion
HK1185557A1 (zh) 水包油型乳化組合物
HK1170128A1 (en) Seasoning in the form of acidic oil-in-water type emulsion
SMT201500297B (it) Emulsione olio-in-acqua di mometasone e propilene glicole
EP2544683A4 (en) SYNERGISTIC EFFECT OF TOCOTRIENOLS AND CURCUMIN
HK1250484A1 (zh) 用於治療胰腺炎的吉卡賓和衍生物
HRP20170170T1 (hr) Emulzija ulje-u-vodi mometazona
ZA201503799B (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
TH126171B (th) อุปกรณ์สำหรับจ่ายเครื่องดื่ม และวิธีการของสิ่งนี้